PEACE-1 study
Analysis of Prostate Cancer Trial Data Supports Change in Standard
New analyses from the PEACE-1 and STAMPEDE multicenter trials demonstrated that the addition of abiraterone acetate ...
DECEMBER 22, 2021
For mCSPC, Abiraterone Plus ADT and Docetaxel Improves rPFS
In men with de novo metastatic castration-sensitive prostate cancer, the addition of abiraterone (Zytiga, Janssen) ...
SEPTEMBER 2, 2021
Load more